Southern Anesthasia + Surgical is a US distributor of anesthesia and surgical supplies to oral surgeons, dental anesthesiologists and periodontists, Melville, N.Y.-based Henry Schein said. The company offers controlled and non-controlled pharmaceuticals and surgical supplies to approximately 11,500 customers, with recorded 2016 sales of $72 million.
“We at Henry Schein are pleased to extend a warm welcome to our new colleagues from SAS as we unite two leading dental-surgical supply companies. SAS’s loyal and long-standing customer relationships and ACE’s standing as a global leader in the dental market greatly enhance our ability to serve the needs of oral surgery practitioners across the U.S. Together, we are able to provide our customers with a wide range of products and value-added services, including bone regeneration materials, that will help them grow their business and provide high-quality care to their patients,” CEO & chair Stanley Bergman said in a prepared statement.
SAS and its 88 employees will become of Henry Schein subsidiary ACE surgical supply company, according to a press release. The SAS business division will continue to be led by its current management team.
“We are delighted with the closing of the transaction and the opportunity to join forces with Henry Schein, the nation’s full-service dental leader. Henry Schein’s well-earned global reputation for excellence in customer service with a commitment to quality patient care, practice success, and innovation, makes the company and its ACE subsidiary an ideal partner as we explore opportunities to serve and grow the SAS customer base,” SAS VP and GM Bill Alexander said in prepared remarks.
“We very much look forward to our partnership with SAS. By combining two well-known and respected brands, we will offer a broader product portfolio focused on the unique needs of the dental surgeon,” ACE prez Craig Carchidi said in a press release.
Last December, Henry Schein made an 80% equity investment in Polish full-service dental distributor Marrodent. Warsaw, Poland-based Marrodent was founded in 1990, and recorded 2015 sales of approximately $32 million
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.